- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-12-0000885

About Stanford Laboratories Private Ltd
Data last updated:
Stanford Laboratories Private Ltd is a private limited company based in New Delhi, Delhi, India, a subsidiary of La Renon Healthcare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 November 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1985PTC022656. Its GSTIN is 02AABCS3288A1ZV (Himachal Pradesh). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Madhusudan Duggal (Managing Director) and Nihit Duggal.
Its last annual general meeting (AGM) was held on 11 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5th Floor Caddie Commercial Tower Aerocity, New Delhi, Delhi, India – 110037.
As per the financials filed for FY 2025, the company reported a revenue of ₹178.12 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹4 Cr (net margin -2.2%) and EBITDA of ₹2.18 Cr (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 13% over five years.
The company has about 301 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Stanford Laboratories. As per MCA filings, the company has open charges of ₹23.65 Cr and satisfied charges of ₹5.76 Cr on record. Court records list 41 cases involving the company, including 12 filed by the company and 29 filed against it; 1 case is pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Lakh; the latest was in April 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Mapra Laboratories Pvt Ltd with revenue of ₹184.45 Cr. The company has 19 MSME Form 1 returns on record between 2019 and 2024, listing 2,337 overdue payments to 92 micro and small suppliers.
Stanford Laboratories Private Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-12-0000885). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stanlabs.com.
Company details
Recognitions & Rankings of Stanford Laboratories
Contact details
Stanford Laboratories Private Ltd's registered office is in New Delhi, Delhi. Its website is stanlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address5th Floor Caddie Commercial Tower Aerocity, New Delhi, Delhi, India – 110037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stanford Laboratories Private Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Stanford Laboratories operates one associated brand: Stanford Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Acts as a contract manufacturer of pharmaceutical formulations. | stanlabs.com |
Business activity
The main business activity of Stanford Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Stanford Laboratories Private Ltd, buy the company report.
Financials of Stanford Laboratories Private Ltd
FY 2025 filings availableStanford Laboratories Private Ltd reported revenue of ₹178.12 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 3% growth in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stanford Laboratories Private Ltd, buy the company report.
Board of directors of Stanford Laboratories Private Ltd
Stanford Laboratories has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhusudan Duggal | Managing Director | 29 Nov 1985 | 40 Years 11 Months | Current |
| Nihit Duggal | Director | 08 Jun 2015 | 11 Years 5 Months | Current |
| Amit Kaushal Also directs: Akassh Lifetech LLP | Director | 10 Jul 2025 | 1 Years 4 Months | Current |
| Dilpeshbhai Jagdishbhai Thakkar | Nominee Director | 10 Jul 2025 | 1 Years 4 Months | Current |
Peer comparison
Stanford Laboratories Private Ltd is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mapra Laboratories Pvt Ltd | ₹184.45 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Naxpar Pharma Private Limited | ₹183.89 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Infutec Healthcare Limited | ₹183.11 Cr (FY 2021) | -22.0% | Mumbai, Maharashtra, India | |||
| Stanford Laboratories Private Ltdthis company | ₹178.12 Cr (FY 2025) | -₹4 Cr | -2.2% | 3.0% | 301 | New Delhi, Delhi, India |
| BDR Lifesciences Private Limited | ₹176.87 Cr (FY 2025) | -5.0% | Vadodara, Gujarat, India | |||
| Bakson Drugs and Pharmaceuticals Private Limited | ₹172.81 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Shree Krishnakeshav Laboratories Limited | ₹170.52 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Stanford Laboratories Private Ltd, buy the company report.
Auditor
Stanford Laboratories Private Ltd is audited by Deloitte Haskins & Sells for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells | FY 2024 | 117365W |
Shareholding
The shareholding of Stanford Laboratories Private Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stanford Laboratories Private Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Jun 2017 | 100111338 | Hdfc Bank Limited | ₹23.65 Cr | Open | |
| 08 Feb 2016 | 10624175 | Punjab National Bank | ₹50 Lakh | Satisfied | |
| 27 Jan 2015 | 10549010 | Punjab National Bank | ₹50 Lakh | Satisfied | |
| 24 Oct 2013 | 10459251 | Punjab National Bank | ₹13.75 Lakh | Satisfied | |
| 21 Dec 2012 | 10399868 | State Bank of India | ₹20 Lakh | Satisfied |
To see the full charge records of Stanford Laboratories Private Ltd, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Stanford Laboratories Private Ltd has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Lakh; the latest was in April 2023.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2023 | Secondary share transfer | Undisclosed | Buyer: La Renon Healthcare Private Limited , LA Renon Healthcare Private Limited & Abhijit Basu Seller: La Renon Healthcare Private Limited , 2 individuals |
| Jun 2015 | Secondary share transfer | Undisclosed | Buyer: La Renon Healthcare Private Limited Seller: 2 individuals |
| Jan 2009 | Funding round | ₹11.5 Lakh | Investors: 2 individuals |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Stanford Laboratories Private Ltd has 41 court cases on record: 12 filed by Stanford Laboratories, 29 filed against it. 1 case is pending and 40 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 35 | 23 | 0 |
| District courts | 4 | 4 | 1 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 41)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Appeal | Filed by the company against Centaur Pharmaceuticals Pvt Ltd and 1 other | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed by the company against Centaur Pharmaceuticals Pvt. Ltd., and 1 other | Disposed |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by Centaur Pharmaceuticals Pvt. Ltd and 1 other | Disposed |
| High Court, TAMIL NADU | Court case (OSA) | Filed against the company by Centaur Pharmaceuticals Pvt. Ltd and 1 other | Disposed |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed against the company by Centaur Pharmaceuticals Pvt. Ltd. Represented by Its Directors Through Rakhi Kadam Authorised Signatory Centaur House, Shantinagar, Vakola,Santacruz (E), Mumbai ,Mumbai , Maharashtra and 1 other | Disposed |
To see the full case history of Stanford Laboratories Private Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Stanford Laboratories Private Ltd has 19 MSME Form 1 returns on record between 2019 and 2024, listing 2,337 overdue payments to 92 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 92)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| S.A. Packaging | |||
| Himachal Pharrma Chems | |||
| an individual supplier | |||
| Caprihans India Limited | |||
| Tiwari Pharma Private Limited |
To see the full MSME payment records of Stanford Laboratories Private Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Stanford Laboratories has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Stanford Lifecare Private Limited | U24304DL2020PTC363402 |
To see the full group structure of Stanford Laboratories Private Ltd, buy the company report.
Employees & EPFO
Stanford Laboratories Private Ltd has a workforce of 301 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 301 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Stanford Laboratories Private Ltd, buy the company report.
GST
Stanford Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AABCS3288A1ZV | Himachal Pradesh | Active | 01 Jul 2017 |
| 06AABCS3288A1ZN | Haryana | Active | 31 Aug 2017 |
To see the full GST registrations and return filing status of Stanford Laboratories Private Ltd, buy the company report.
Recent activity
Stanford Laboratories Private Ltd has 14 board changes on record since 1985: 4 appointments and 10 cessations. The latest: Amit Kaushal ceased to be Additional Director on 10 Aug 2025.
25 earlier events are in the company report.
Frequently asked questions
Stanford Laboratories is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 November 1985 (41+ years old) and is registered under CIN U74899DL1985PTC022656.
Stanford Laboratories has 4 current directors:
- Madhusudan Duggal - Managing Director
- Nihit Duggal - Director
- Amit Kaushal - Director
- Dilpeshbhai Jagdishbhai Thakkar - Nominee Director
The latest financial statements of Stanford Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Stanford Laboratories is 02AABCS3288A1ZV, registered in Himachal Pradesh. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 06AABCS3288A1ZN (Haryana).
The CIN (Corporate Identification Number) of Stanford Laboratories is U74899DL1985PTC022656. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stanford Laboratories has 41 court cases on record: 12 filed by the company and 29 filed against it. 1 is pending. Most are in the high courts.
Stanford Laboratories was incorporated on 29 November 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Stanford Laboratories has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹11.5 Lakh; the latest was in April 2023.
The peers of Stanford Laboratories by revenue are Mapra Laboratories Pvt Ltd, Naxpar Pharma Private Limited, Infutec Healthcare Limited, BDR Lifesciences Private Limited, Bakson Drugs and Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Kaushal ceased to be Additional Director on 10 Aug 2025. Dilpeshbhai Jagdishbhai Thakkar ceased to be Additional Director on 10 Aug 2025. Amit Kaushal was appointed as Director on 10 Jul 2025. Stanford Laboratories has 14 board changes on record in total.
Yes, Stanford Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-12-0000885).
Stanford Laboratories has 19 MSME Form 1 returns on record between 2019 and 2024, listing 2,337 overdue payments to 92 micro and small suppliers. The latest return was filed on 25 Apr 2024.

